Evidence map›Paper›PMID 39373721›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Targeted K-Edge Nanoprobes From Praseodymium and Hafnium for Ratiometric Tracking of Dual Biomarkers using Spectral Photon Counting CT.

Nivetha Gunaseelan, Parikshit Moitra, Pranay Saha, Teresa Aditya, Mahdieh Moghiseh, Kevin Jonker, Steven Gieseg, Anthony Butler, Fadia Kamal, Dipanjan Pan

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nivetha GunaseelanHuck Institutes of the Life Sciences, Department(s) of Biomedical Engineering, Nuclear Engineering, Materials Science and Engineering, The Pennsylvania State University, 101 Huck Life Sciences Building, University Park PA, 16802, USA.ORCID 0000-0003-4939-1658
Parikshit MoitraHuck Institutes of the Life Sciences, Department(s) of Biomedical Engineering, Nuclear Engineering, Materials Science and Engineering, The Pennsylvania State University, 101 Huck Life Sciences Building, University Park PA, 16802, USA.ORCID 0000-0002-7679-7859
Pranay SahaHuck Institutes of the Life Sciences, Department(s) of Biomedical Engineering, Nuclear Engineering, Materials Science and Engineering, The Pennsylvania State University, 101 Huck Life Sciences Building, University Park PA, 16802, USA.
Teresa AdityaHuck Institutes of the Life Sciences, Department(s) of Biomedical Engineering, Nuclear Engineering, Materials Science and Engineering, The Pennsylvania State University, 101 Huck Life Sciences Building, University Park PA, 16802, USA.
Mahdieh MoghisehMARS Bioimaging Limited, 68 Saint Asaph Street, Christchurch Central City, Christchurch, 8011, New Zealand.
Kevin JonkerMARS Bioimaging Limited, 68 Saint Asaph Street, Christchurch Central City, Christchurch, 8011, New Zealand.
Steven GiesegMARS Bioimaging Limited, 68 Saint Asaph Street, Christchurch Central City, Christchurch, 8011, New Zealand.
Anthony ButlerMARS Bioimaging Limited, 68 Saint Asaph Street, Christchurch Central City, Christchurch, 8011, New Zealand.
Fadia KamalCenter for Orthopaedic Research and Translational Science, Department of Orthopaedics and Rehabilitation, Penn State College of Medicine, The Pennsylvania State University, Hershey, PA, 17033, USA.
Dipanjan PanHuck Institutes of the Life Sciences, Department(s) of Biomedical Engineering, Nuclear Engineering, Materials Science and Engineering, The Pennsylvania State University, 101 Huck Life Sciences Building, University Park PA, 16802, USA.ORCID 0000-0003-0175-4704

Funding

CDC HHS 75D30122C15492Congressionally Directed Medical Research Programs TP210376Department of DefenseNational Science Foundation CBET 2153091/2229986
6 · The paper itself

Abstract

Utilizing metal nanoprobes with unique K-edge identities to visualize complementary biological activities simultaneously can provide valuable information about complex biological processes. This study describes the design and preparation of an innovative pair of K-edge metal nanoprobes and demonstrates the feasibility of their simultaneous quantitative detection using spectral photon-counting computed tomography (SPCCT). Glycosaminoglycan (GAG) capped nanoparticles (ca. 15-20 nm) targeting two distinct components of the cartilage tissue, namely, aggrecan (acan) and aggrecanase (acanase) are designed and synthesized. These targeted nanoparticles comprised of praseodymium (Pr) and hafnium (Hf), with well-separated K-edge energies, enable simultaneous and ratiometric imaging of dual biomarkers in cartilage tissue. Following extensive physico-chemical characterization of the ligand-targeted particles, the feasibility of homing dual biomarkers in vitro is demonstrated. The material discrimination and simultaneous quantification of these targeted particles are also achieved and corroborated with inductively coupled plasmon spectroscopy. For the first time, the use of praseodymium is reported as a contrast agent for SPCCT imaging and demonstrates the ability to pair it with hafnium nanoprobes for multicontrast imaging of diseases. Importantly, the potential for ratiometric molecular imaging and tracking of osteoarthritis (OA) progression is shown with SPCCT K-edge based imaging approach.

Indexed as

BiomarkersHafniumPraseodymiumTomography, X-Ray ComputedAnimalsGlycosaminoglycansHumansMetal NanoparticlesOsteoarthritisPhotonsBiomarkersGlycosaminoglycansHafniumPraseodymiumhafnium nanoparticlesK‐edge imagingosteoarthritis trackingpraseodymium nanoparticlesquantitative imagingspectral photon counting computed tomography

Identifiers

PMID39373721
PMCPMC11633496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.